Hudson AL - Search Results

1

From mice to men: GEMMs as trial patients for new NSCLC therapies.

Hayes SA, Hudson AL, Clarke SJ, Molloy MP, Howell VM. Hayes SA, et al. Among authors: hudson al. Semin Cell Dev Biol. 2014 Mar;27:118-27. doi: 10.1016/j.semcdb.2014.04.002. Epub 2014 Apr 6. Semin Cell Dev Biol. 2014. PMID: 24718320 Review.

2

SV40 TAg mouse models of cancer.

Colvin EK, Weir C, Ikin RJ, Hudson AL. Colvin EK, et al. Among authors: hudson al. Semin Cell Dev Biol. 2014 Mar;27:61-73. doi: 10.1016/j.semcdb.2014.02.004. Epub 2014 Feb 25. Semin Cell Dev Biol. 2014. PMID: 24583142 Review.

3

Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines.

Weir C, Hudson AL, Moon E, Ross A, Alexander M, Peters L, Langova V, Clarke SJ, Pavlakis N, Davey R, Howell VM. Weir C, et al. Among authors: hudson al. Cancer Immunol Res. 2014 May;2(5):469-79. doi: 10.1158/2326-6066.CIR-13-0157. Epub 2014 Feb 21. Cancer Immunol Res. 2014. PMID: 24795359

4

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.

Hudson AL, Weir C, Moon E, Harvie R, Klebe S, Clarke SJ, Pavlakis N, Howell VM. Hudson AL, et al. Sci Rep. 2014 Aug 21;4:6152. doi: 10.1038/srep06152. Sci Rep. 2014. PMID: 25141917 Free PMC article.

5

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model.

Weir CJ, Hudson AL, Peters L, Howell VM. Weir CJ, et al. Among authors: hudson al. J Vis Exp. 2015 Oct 2;(104):53019. doi: 10.3791/53019. J Vis Exp. 2015. PMID: 26485154 Free PMC article.

6

Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.

Parker NR, Hudson AL, Khong P, Parkinson JF, Dwight T, Ikin RJ, Zhu Y, Cheng ZJ, Vafaee F, Chen J, Wheeler HR, Howell VM. Parker NR, et al. Among authors: hudson al. Sci Rep. 2016 Mar 4;6:22477. doi: 10.1038/srep22477. Sci Rep. 2016. PMID: 26940435 Free PMC article.

7

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment.

Hudson AL, Parker NR, Khong P, Parkinson JF, Dwight T, Ikin RJ, Zhu Y, Chen J, Wheeler HR, Howell VM. Hudson AL, et al. Front Oncol. 2018 Aug 13;8:314. doi: 10.3389/fonc.2018.00314. eCollection 2018. Front Oncol. 2018. PMID: 30151353 Free PMC article.

8

BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state.

Rath EM, Cheng YY, Pinese M, Sarun KH, Hudson AL, Weir C, Wang YD, Håkansson AP, Howell VM, Liu GJ, Reid G, Knott RB, Duff AP, Church WB. Rath EM, et al. Among authors: hudson al. PLoS One. 2018 Aug 29;13(8):e0203003. doi: 10.1371/journal.pone.0203003. eCollection 2018. PLoS One. 2018. PMID: 30157247 Free PMC article.

9

Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer.

McKelvey KJ, Hudson AL, Prasanna Kumar R, Eade T, Clarke SJ, Wheeler HR, Diakos CI, Howell VM. McKelvey KJ, et al. Among authors: hudson al. Front Oncol. 2020 Jan 14;9:1504. doi: 10.3389/fonc.2019.01504. eCollection 2019. Front Oncol. 2020. PMID: 32010614 Free PMC article.

10

Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model.

McKelvey KJ, Hudson AL, Prasanna Kumar R, Wilmott JS, Attrill GH, Long GV, Scolyer RA, Clarke SJ, Wheeler HR, Diakos CI, Howell VM. McKelvey KJ, et al. Among authors: hudson al. PLoS One. 2020 Apr 2;15(4):e0226444. doi: 10.1371/journal.pone.0226444. eCollection 2020. PLoS One. 2020. PMID: 32240177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page